News

Luiz Pompeu publishes an article on the Capital Aberto portal about adjustments to the CMV’s illustrative list of material facts

Share

Our lawyer Luiz Pompeu published an article on the Capital Aberto portal proposing adjustments to the Brazilian Securities and Exchange Commission’s (CVM) illustrative list of material facts.

The Brazilian Corporations Law requires publicly traded companies to disclose any material facts that may influence investors’ decisions.

However, this assessment can be complex. For this reason, since 1984, the CVM has provided an illustrative list of potentially material facts.

Although the list facilitates the identification of this information, it also imposes on the Investor Relations Officer (DRI) the burden of justifying the decision not to disclose, or to disclose in a different manner, events provided for therein, in addition to generating fear of liability and inducing the disclosure as a material fact of any event contained in the list.

The CVM is currently analyzing contributions on the subject (in Public Consultation SDM No. 01/2025), including possible adjustments to the list.

For Luiz, the ideal solution would be to create an illustrative list of objectively (rather than potentially) material facts, which could provide greater legal certainty for the IR Director’s actions and reduce the risks of liability.

Read the full article.

Authors

news

You may also be interested in

Mauricio Jayme e Silva is a...

Our partner Mauricio Jayme e Silva joined the Capital Markets Committee of the São Paulo Bar Association (OAB SP) at the end of July. The Committee promotes the study and discussion of strategic issues aimed at strengthening and modernising the capital markets in Brazil. Congratulations, Mauricio! We wish…

Bernardo da Costa e Silva takes...

Our partner Bernardo da Costa e Silva spoke to *Valor Econômico* in a report covering yesterday’s (25 August) decision by the Board of the Brazilian Securities and Exchange Commission (CVM) in favour of the takeover bid for Oncoclínicas, valued at around R$ 6.5 billion. The newspaper reported that…